References

No references inside the corpus for this window.

Cited by

• 1992Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor117 cited
• 2012Optimal treatment of social phobia: systematic review and meta-analysis107 cited
• 1995Social phobia: the clinical efficacy and tolerability of the monoamine oxidase ‐A and serotonin uptake inhibitor brofaromine. A double‐blind placebo‐controlled study104 cited
• 1996Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia95 cited
• 1997Moclobemide in social phobia93 cited
• 2001The prediction of nonresponse to pharmacotherapy in panic disorder: A review88 cited
• 2002Pharmacotherapy of social anxiety disorder88 cited
• 1994A prospective follow-along study of the course of social phobia84 cited
• 2000Comorbid Generalized Anxiety Disorder in Primary Social Phobia80 cited
• 2000A Review of the Epidemiology and Approaches to the Treatment of Social Anxiety Disorder79 cited
• 2003Pharmacotherapy of social phobia69 cited
• 2002Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder65 cited
• 2000Bupropion-SR in treatment of social phobia54 cited
• 1991